Wolverine Trading’s GeneDx Holdings WGS Stock Holding History

Wolverine Trading’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$4.23M	Sell	37,100 -13,800	-27%	-$1.5M	﹤0.01%	1516
2025 Q2	$4.64M	Buy	50,900 +34,700	+214%	+$2.72M	﹤0.01%	1104
2025 Q1	$1.49M	Buy	16,200 +3,800	+31%	+$330K	﹤0.01%	1875
2024 Q4	$950K	Sell	12,400 -1,200	-9%	-$83.8K	﹤0.01%	2704
2024 Q3	$582K	Buy	+13,600	New	+$459K	﹤0.01%	2912
2023 Q3	–	Sell	-38,900	Closed	-$248K	–	5202
2023 Q2	$248K	Buy	38,900 +37,930	+3,910%	+$300K	﹤0.01%	3297
2023 Q1	$10K	Buy	+970	New	+$12.9K	﹤0.01%	4076
2022 Q2	–	Sell	-3,094	Closed	-$319K	–	5856
2022 Q1	$319K	Buy	3,094 +2,785	+901%	+$310K	﹤0.01%	3804
2021 Q4	$47K	Sell	309 -249	-45%	-$55.6K	﹤0.01%	5343
2021 Q3	$137K	Buy	+558	New	+$192K	﹤0.01%	5608

Other funds holding WGS

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Wolverine Trading's WGS Position: Q3 2025 in Review

Wolverine Trading sold out of GeneDx Holdings (WGS) in Q3 2025, closing a stake of 3,313 shares — an estimated $361K sold.

Wolverine Trading first reported a position in WGS in Q2 2021 and held it in 6 quarters. The position peaked at $857K in Q1 2025. 268 funds tracked by Wall St. Rank hold WGS as of Q3 2025.

Wolverine Trading reported no remaining GeneDx Holdings position as of Q3 2025 after selling out during the quarter.
Wolverine Trading sold 3,313 GeneDx Holdings shares in Q3 2025, an estimated $361K.
Wolverine Trading first reported a position in GeneDx Holdings in Q2 2021 and held it in 6 quarters.
Wolverine Trading's GeneDx Holdings position peaked at $857K in Q1 2025.
268 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.